drugset / Trial / NCT03152890
Insulin Therapy for Postreperfusion Hyperglycemia
NaSingle-groupOpen-labelTreatment
Summary
Glycemic control during liver transplantation is challenging especially after reperfusion of the liver graft. Insulin dose to treat postreperfusion hyperglycemia is retrospectively analyzed using historical data. The proposed dose then is prospectively applied to the patients to assess the adequacy of the insulin dose.
Timeline
- Start
- 2017-05-15
- Primary completion
- 2024-12-15
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | — |